The Trump Administration: Seven More Things To Watch Out For

Beyond pricing, industry experts weigh in on how the next administration has shifted expectations across a range of areas – including tax reform, FDA standards and the Cancer Moonshot Initiative.

Watch gears up close

Nobody has a crystal ball to show what life will be like in the biopharma world under the incoming Trump administration, but industry experts were willing to share some personal predictions during panels at the Biotech Showcase meeting in San Francisco, held in parallel with the J.P. Morgan Healthcare conference.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Elections

More from Legislation